Literature DB >> 24526004

LPS response pattern of inflammatory adipokines in an in vitro 3T3-L1 murine adipocyte model.

Salvatore Chirumbolo1, Guido Franceschetti, Elena Zoico, Clara Bambace, Luciano Cominacini, Mauro Zamboni.   

Abstract

OBJECTIVE: In vitro 3T3-L1 mouse cells represent a reliable model to investigate the inflammatory phenotype of adipocytes activated by bacteria-derived lipopolysaccharide (LPS). In this study we have evaluated the differential expression of adipokines in response to increasing doses of LPS and various incubation times.
METHODS: 3T3-L1 mouse adipocytes were treated with E. coli LPS (from 0 to 10 μg/ml) for a time course ranging from 4 to 24 h, 4 h each. A time point at 2 h was also included to highlight early activation by LPS. mRNA expression by RT-PCR on cell lysates and ELISA assays on cell culture supernatants were performed.
RESULTS: Cells activated by increasing doses of LPS upregulated TNF-α expression in the first 2 h, but this expression slowed down within 6-8 h, while IL-6 expression was increasing. This reduction was also observed for CXCL12/SDF1α. Unlike IL-10, IL-6 expression was constantly upregulated by prolonging incubation with LPS. TNF-α and CXCL12 gene expression occurred early in the time-course and exhibited a second increase following the first 4-6 h of incubation with LPS. Optimal expression of most adipokines needed 6-8 h of a prolonged treatment with LPS at 37 °C. The chemokines MIP-1α/CCL3 and MIP-1β/CCL4 were maximally expressed within the first 8 h, then significantly reduced in the following times. IL-10 expression was upregulated by low doses of LPS and downregulated by prolonging time with the bacterial endotoxin. ELISA analysis of released products generally confirmed the result from gene expression experiments.
CONCLUSION: These data, while assessing previously reported results, highlighted new evidence about the time-dependency in LPS-mediated adipokine production, thus contributing to the comprehension of the inflammatory response of adipocyte.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24526004     DOI: 10.1007/s00011-014-0721-9

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  62 in total

1.  Chemokines and their receptors in the CNS: expression of CXCL12/SDF-1 and CXCR4 and their role in astrocyte proliferation.

Authors:  Rudy Bonavia; Adriana Bajetto; Simone Barbero; Paolo Pirani; Tullio Florio; Gennaro Schettini
Journal:  Toxicol Lett       Date:  2003-04-04       Impact factor: 4.372

Review 2.  Roles of chemokine CXCL12 and its receptors in ischemic stroke.

Authors:  Yongting Wang; Jun Huang; Yaning Li; Guo-Yuan Yang
Journal:  Curr Drug Targets       Date:  2012-02       Impact factor: 3.465

Review 3.  CXCL12: a new player in coronary disease identified through human genetics.

Authors:  Samira S Farouk; Daniel J Rader; Muredach P Reilly; Nehal N Mehta
Journal:  Trends Cardiovasc Med       Date:  2010-08       Impact factor: 6.677

4.  Relation of chemokines to BMI and insulin resistance at ages 18-21.

Authors:  S Ognjanovic; D R Jacobs; J Steinberger; A Moran; A R Sinaiko
Journal:  Int J Obes (Lond)       Date:  2012-04-17       Impact factor: 5.095

5.  Both adiponectin and interleukin-10 inhibit LPS-induced activation of the NF-κB pathway in 3T3-L1 adipocytes.

Authors:  Fábio Santos Lira; José Cesar Rosa; Gustavo Duarte Pimentel; Marília Seelaender; Ana Raimunda Damaso; Lila Missae Oyama; Claudia Oller do Nascimento
Journal:  Cytokine       Date:  2011-11-01       Impact factor: 3.861

6.  Microarray profiling of isolated abdominal subcutaneous adipocytes from obese vs non-obese Pima Indians: increased expression of inflammation-related genes.

Authors:  Y H Lee; S Nair; E Rousseau; D B Allison; G P Page; P A Tataranni; C Bogardus; P A Permana
Journal:  Diabetologia       Date:  2005-07-30       Impact factor: 10.122

7.  Inflammatory activation in children with primary hypertension.

Authors:  Mieczyslaw Litwin; Jacek Michałkiewicz; Anna Niemirska; Lidia Gackowska; Lidia Gockowska; Izabela Kubiszewska; Aldona Wierzbicka; Zbigniew T Wawer; Roman Janas
Journal:  Pediatr Nephrol       Date:  2010-05-21       Impact factor: 3.714

8.  DNA microarray analyses of genes expressed differentially in 3T3-L1 adipocytes co-cultured with murine macrophage cell line RAW264.7 in the presence of the toll-like receptor 4 ligand bacterial endotoxin.

Authors:  A Yamashita; Y Soga; Y Iwamoto; T Asano; Y Li; Y Abiko; F Nishimura
Journal:  Int J Obes (Lond)       Date:  2008-09-09       Impact factor: 5.095

9.  LPS-induced migration of peritoneal B-1 cells is associated with upregulation of CXCR4 and increased migratory sensitivity to CXCL12.

Authors:  Hana Moon; Jae-Ghi Lee; Sang Hyuck Shin; Tae Jin Kim
Journal:  J Korean Med Sci       Date:  2011-12-19       Impact factor: 2.153

10.  Chemokines control fat accumulation and leptin secretion by cultured human adipocytes.

Authors:  C C Gerhardt; I A Romero; R Cancello; L Camoin; A D Strosberg
Journal:  Mol Cell Endocrinol       Date:  2001-04-25       Impact factor: 4.102

View more
  14 in total

1.  IL-25 directly modulates adipocyte function and inflammation through the regulation of adiponectin.

Authors:  Siranart Jeerawattanawart; Pilaiwan Siripurkpong; Sittiruk Roytrakul; Pornpimon Angkasekwinai
Journal:  Inflamm Res       Date:  2022-07-12       Impact factor: 6.986

Review 2.  The sesquiterpene α-bisabolol in the adipocyte-cancer desmoplastic crosstalk: does it have an action on epithelial-mesenchymal transition mechanisms?

Authors:  Salvatore Chirumbolo; Geir Bjørklund
Journal:  Int J Clin Oncol       Date:  2016-12-09       Impact factor: 3.402

3.  Antioxidant polyphenol-rich extracts from the medicinal plants Antirhea borbonica, Doratoxylon apetalum and Gouania mauritiana protect 3T3-L1 preadipocytes against H2O2, TNFα and LPS inflammatory mediators by regulating the expression of superoxide dismutase and NF-κB genes.

Authors:  Marie-Paule Gonthier; Christine Robert-Da Silva; Méry Marimoutou; Fanny Le Sage; Jacqueline Smadja; Christian Lefebvre d'Hellencourt
Journal:  J Inflamm (Lond)       Date:  2015-02-08       Impact factor: 4.981

Review 4.  Integrated Immunomodulatory Mechanisms through which Long-Chain n-3 Polyunsaturated Fatty Acids Attenuate Obese Adipose Tissue Dysfunction.

Authors:  Danyelle M Liddle; Amber L Hutchinson; Hannah R Wellings; Krista A Power; Lindsay E Robinson; Jennifer M Monk
Journal:  Nutrients       Date:  2017-11-27       Impact factor: 5.717

5.  Torenia concolor Lindley var. formosana Yamazaki extracts improve inflammatory response and lipid accumulation via PPARs activation.

Authors:  Yu-Chia Liang; Jun-Cheng Hu; Pei-Ying Li; Guan-Jhong Huang; Yueh-Hsiung Kuo; Che-Yi Chao
Journal:  Biomedicine (Taipei)       Date:  2017-08-25

6.  Inflammation Downregulates UCP1 Expression in Brown Adipocytes Potentially via SIRT1 and DBC1 Interaction.

Authors:  Mark K Nøhr; Natalia Bobba; Bjørn Richelsen; Sten Lund; Steen B Pedersen
Journal:  Int J Mol Sci       Date:  2017-05-08       Impact factor: 5.923

7.  Fungal-like particles and macrophage-conditioned medium are inflammatory elicitors for 3T3-L1 adipocytes.

Authors:  Chanawee Jakkawanpitak; Nongporn Hutadilok-Towatana; Decha Sermwittayawong
Journal:  Sci Rep       Date:  2020-06-10       Impact factor: 4.379

8.  Intranasal brain delivery of cationic nanoemulsion-encapsulated TNFα siRNA in prevention of experimental neuroinflammation.

Authors:  Sunita Yadav; Srujan K Gandham; Riccardo Panicucci; Mansoor M Amiji
Journal:  Nanomedicine       Date:  2016-01-06       Impact factor: 5.307

9.  Inhibition of Lipid Accumulation and Cyclooxygenase-2 Expression in Differentiating 3T3-L1 Preadipocytes by Pazopanib, a Multikinase Inhibitor.

Authors:  Anil Kumar Yadav; Byeong-Churl Jang
Journal:  Int J Mol Sci       Date:  2021-05-05       Impact factor: 5.923

10.  Potential Anti-Diabetic Activity of Pueraria lobata Flower (Flos Puerariae) Extracts.

Authors:  Pattawika Lertpatipanpong; Sakawrat Janpaijit; Eul-Yong Park; Chong-Tai Kim; Seung Joon Baek
Journal:  Molecules       Date:  2020-08-31       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.